secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardio Diagnostics Holdings, Inc. (CDIO)
CIK:        0001870144
Form:       8-K
Filed at:   2022-09-15T23:59:59+00:00
Accession:  0001079973-22-001114
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mana Capital and Cardio Diagnostics Amend Merger Agreement to Increase Incentive Plan Shares and Provide Equity to UIRF
--------------------------------------------------------------------------------

- Amendment dated September 15, 2022 increases shares reserved under Cardio Diagnostics Holdings 2022 Incentive Plan to 3,265,516.
- Upon closing, University of Iowa Research Foundation to receive 1% of aggregate merger consideration as common stock of Mana Capital.
- Amendment modifies treatment of Company Equity Rights and adjusts Exchange Ratio definition in the Merger Agreement.
- Other terms of the original Merger Agreement dated May 27, 2022 remain in full force and effect.
- Business combination still subject to stockholder approval and customary closing conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870144/000107997322001114/0001079973-22-001114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870144/000107997322001114/mana_8k-091522.htm
  HTML page:      https://secwatch.observer/filing/0001079973-22-001114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer